Supplementary Table S4 from Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment <i>In Vitro</i> and <i>In Vivo</i>
收藏NIAID Data Ecosystem2026-04-30 收录
数据链接:
官方服务:
资源简介:
Supplementary Table S4
创建时间:
2023-01-03




